Novartis (Japan)
About
In recent decades, authors affiliated with Novartis (Japan) have published 439 papers, which have received a total of 9.7k indexed citations.
Scholars at this organization have produced 146 papers in Molecular Biology, 84 papers in Oncology and 64 papers in Pulmonary and Respiratory Medicine on the topics of Asthma and respiratory diseases (39 papers), Proteoglycans and glycosaminoglycans research (21 papers) and Respiratory and Cough-Related Research (20 papers). Their work is cited by papers focused on Molecular Biology (4.0k citations), Oncology (1.7k citations) and Cell Biology (1.6k citations). Authors at Novartis (Japan) collaborate with scholars in Japan, Switzerland and United States and have published in prestigious journals including New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology. Some of Novartis (Japan)'s most productive authors include Motowo Nakajima, Yoshio Naomoto, Takeshi Tajima, Shinji Hatakeyama and Munenori Takaoka.
In The Last Decade
Fields of papers published by authors at Novartis (Japan)
Since SpecializationEngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics
This network shows the specialization of papers affiliated with Novartis (Japan) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.
Countries citing scholars working at Novartis (Japan)
Since SpecializationCitations
This map shows the geographic impact of research produced by authors working at Novartis (Japan). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novartis (Japan) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novartis (Japan) more than expected).
Explore institutions with similar magnitude of impact
Breakdown of academic impact, for scholars at Izumi City General Hospital Breakdown of academic impact, for scholars at Associazione Italiana Sclerosi Multipla Breakdown of academic impact, for scholars at Shanghai CASB Biotechnology (China) Breakdown of academic impact, for scholars at CJ CheilJedang (South Korea) Breakdown of academic impact, for scholars at Language Science (South Korea) Breakdown of academic impact, for scholars at Kliniken Schmieder Breakdown of academic impact, for scholars at Varian Medical Systems (Switzerland) Breakdown of academic impact, for scholars at Vlaamse Vereniging voor Obstetrie en Gynaecolo